Management of Acute Basilar Artery Occlusion Within 4.5 Hours
Administer intravenous thrombolysis (IVT) immediately and proceed urgently to endovascular thrombectomy (EVT)—combined IVT+EVT is superior to either therapy alone for basilar artery occlusion within 4.5 hours. 1
Immediate Treatment Algorithm
Step 1: Initiate IVT Without Delay
- Administer alteplase 0.9 mg/kg (maximum 90 mg) intravenously immediately upon confirming basilar artery occlusion on CT angiography and excluding hemorrhage 1
- The 2024 ESO-ESMINT guidelines provide expert consensus (10/10 voting members) supporting IVT for basilar artery occlusion within 4.5 hours when no contraindications exist 1
- Do not wait for EVT availability to start IVT—time is critical in basilar occlusion given its catastrophic natural history
Step 2: Simultaneous EVT Preparation
- Activate the neurointerventional team immediately while IVT is being administered
- Combined IVT+EVT provides better outcomes than direct EVT alone (weak recommendation, low quality evidence) 1
- EVT within 6 hours shows clear benefit, with adjusted OR 3.804 for favorable functional outcome compared to medical therapy alone 2
Step 3: Confirm Imaging Eligibility
Before proceeding, verify:
- Posterior circulation ASPECTS (pc-ASPECTS) ≥7: Patients with scores 7-10 should receive reperfusion therapy 1
- Absence of extensive bilateral or brainstem ischemic changes: 7/10 guideline members suggest against reperfusion if very extensive bilateral/brainstem lesions present 1
- Basilar occlusion confirmed on CT angiography 3
Technical Approach for EVT
First-Line Thrombectomy Technique
Use direct aspiration (ADAPT technique) as the initial mechanical thrombectomy strategy, with stent retriever as rescue therapy if aspiration fails 1. The 2024 guidelines suggest aspiration over stent retriever as first-line (very low quality evidence, weak recommendation).
Target Recanalization
- Aim for TICI 2b-3 recanalization, which independently predicts favorable outcome (adjusted OR 5.117) 2
- Final recanalization rates exceed 90% with combined approach 4
Critical Prognostic Factors
Favorable outcomes are more likely with:
- Lower baseline NIHSS score (adjusted OR 0.926 per point decrease) 2
- Higher pc-ASPECTS (adjusted OR 1.681 per point increase) 2
- Younger age (adjusted OR 0.978 per year) 2
- Absence of diabetes mellitus (adjusted OR 0.482 if diabetic) 2
Important Caveats
When to Reconsider Aggressive Therapy
For patients with NIHSS <10, the evidence is less clear—best medical therapy was non-significantly better and safer than EVT in this subgroup 1, 5. However, within 4.5 hours with no contraindications, the expert consensus still favors combined therapy given the devastating natural history of untreated basilar occlusion.
Hemorrhagic Risk
- Symptomatic intracranial hemorrhage occurs in 7-11% of IVT-treated basilar occlusion patients 1
- This risk is acceptable given mortality rates of 43-46% with IVT alone versus 31% with EVT 6
Time-Sensitive Execution
The staged escalation approach (IVT followed by on-demand EVT) allows early treatment initiation while maintaining excellent recanalization rates 4. Do not delay IVT to arrange EVT—historical data shows up to 50% favorable outcomes with IVT alone when pc-ASPECTS ≥8 1.
Post-Procedure Management
If EVT is complicated (failed recanalization, imminent re-occlusion, or requires rescue angioplasty/stenting):
- Consider add-on antithrombotic therapy during or within 24 hours post-EVT as rescue strategy after assessing bleeding risk 1
- This applies only when no concomitant IVT was given or EVT procedure was complicated
The evidence strongly supports aggressive reperfusion therapy for basilar artery occlusion within 4.5 hours, as untreated basilar occlusion carries catastrophic prognosis with mortality exceeding 80-90% 1. The combination of IVT+EVT leverages the speed of pharmacological therapy with the superior recanalization rates of mechanical intervention 4.